Key facts
- SocialMama’s last known valuation is $18.0M (Dec 2024).
- It has raised $3.0M; the latest was Seed Round ($3.0M) in Dec 2024.
- Notable investors include Techstars, Connetic Ventures, Wormhole Capital, HearstLab, Regatta Capital Group — 11 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 11 names
- ·Watchlist + deal alerts for SocialMama
- ·The full record, as it builds
Funding rounds
No funding rounds for SocialMama are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About SocialMama
Developer of a doctor-vetted AI platform designed to deliver personalized, empathetic care across every stage of a woman's life from first period to post-menopause. The company's platform offers an intelligent layer of support that adapts to each user's needs, emotional context, and lived experience and provides medically grounded, conversational care, enabling women to navigate everything from symptom tracking to emotional overwhelm with guidance that's trustworthy, culturally attuned, and always accessible.
- Sector
- Information Technology
- HQ
- Houston, TX, United States
- Founded
- 2019
- Employees
- 17
- Website
- emahealth.ai/
- Ownership
- Privately Held (backing)
SocialMama doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in SocialMama shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on SocialMama in its N-PORT filings yet. We sweep new filings monthly.